ClinicalMetric / Countries / Japan / gastrointestinal stromal neoplasms
← 🇯🇵 Japan Trials
🇯🇵 Japan Country × Condition

gastrointestinal stromal neoplasms Clinical Trials in Japan

Active clinical trials for gastrointestinal stromal neoplasms with research sites in Japan. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 Phases: Phase 3 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇯🇵 Japan

Active Trials in Japan (1)

NCT07585266 Phase 3
Recruiting

A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)

Enrollment
800 pts
Country
🇯🇵 Japan
GlaxoSmithKline
View Trial →

Frequently Asked Questions

How many gastrointestinal stromal neoplasms clinical trials are active in Japan?
There are currently 1 active clinical trials for gastrointestinal stromal neoplasms with sites in Japan, of which 1 are actively recruiting patients.
How can I join a gastrointestinal stromal neoplasms clinical trial in Japan?
To join a gastrointestinal stromal neoplasms clinical trial in Japan, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Japan directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are gastrointestinal stromal neoplasms trials in Japan?
Active gastrointestinal stromal neoplasms trials in Japan span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Japan Trials → Global gastrointestinal stromal neoplasms Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology